1.2 Pharmacology of Major Drug Classes
Key Takeaways
- CNS depressants (alcohol, benzodiazepines, opioids, barbiturates) slow brain activity; combining them dramatically increases overdose risk.
- Withdrawal from alcohol, benzodiazepines, and barbiturates can be fatal; opioid and stimulant withdrawal is rarely fatal but extremely uncomfortable.
- Opioids cause respiratory depression by acting on mu receptors; naloxone reverses this by displacing opioids from those receptors.
- Route of administration shapes addiction risk: smoking and IV use produce the fastest peak and the strongest reinforcement.
- Half-life predicts withdrawal timing — short half-life drugs (heroin, alprazolam) produce earlier and sharper withdrawal than long half-life drugs (methadone, diazepam).
Pharmacology Fundamentals
Before the drug classes, four concepts appear across nearly every pharmacology item on the ADC exam:
- Route of administration — IV and smoked routes produce the fastest peak (seconds to minutes) and the highest abuse liability; oral routes are slowest.
- Onset and peak — how quickly subjective effects start and reach maximum.
- Half-life (t½) — time for plasma concentration to fall by 50%. Short half-life predicts faster, sharper withdrawal; long half-life predicts delayed, protracted withdrawal.
- Mechanism — which neurotransmitter system the drug acts on (GABA, mu opioid, dopamine, serotonin, glutamate, cannabinoid).
Two additional terms recur: an agonist activates a receptor (heroin, methadone), a partial agonist activates it with a ceiling (buprenorphine), and an antagonist blocks it (naloxone, naltrexone). Knowing these labels lets you predict overdose reversal and medication-assisted treatment behavior.
CNS Depressants
Depressants slow central nervous system activity by enhancing GABA (the brain's main inhibitory transmitter) or, for opioids, by activating mu opioid receptors. The risk of fatal overdose comes from respiratory depression, especially when depressants are combined.
| Drug | Mechanism | Typical Half-Life | Key Risk |
|---|---|---|---|
| Alcohol (ethanol) | Enhances GABA, blocks NMDA glutamate | ~4-5 hr (zero-order kinetics ~one standard drink/hr) | Fatal withdrawal (DTs), liver disease |
| Benzodiazepines (alprazolam, lorazepam, diazepam, clonazepam) | Positive allosteric modulators at GABA-A | Short (alprazolam ~12 hr) to long (diazepam 20-100 hr active metabolites) | Potentially fatal withdrawal seizures |
| Barbiturates (phenobarbital) | Direct GABA-A agonists at high doses | Long | Narrow therapeutic index; fatal overdose and withdrawal |
| Opioids (heroin, fentanyl, oxycodone, hydrocodone, morphine) | Mu opioid agonists | Heroin ~30 min; fentanyl IV ~2-4 hr; methadone 8-59 hr; buprenorphine 24-42 hr | Respiratory depression and overdose death |
| GHB | GABA-B agonist | ~30 min | Rapid loss of consciousness; sedative-hypnotic withdrawal |
High-yield pairing: Benzodiazepines + opioids + alcohol is the most lethal combination because all three suppress respiratory drive. Most opioid overdose deaths in the United States now involve illicitly manufactured fentanyl, which is roughly 50–100 times more potent than morphine and frequently contaminates the street supply. Counselors should normalize take-home naloxone for every opioid client and family.
CNS Stimulants
Stimulants increase dopamine and norepinephrine activity in the brain.
| Drug | Mechanism | Half-Life | Notable Features |
|---|---|---|---|
| Cocaine | Blocks dopamine reuptake | ~1 hr (crack ~15 min smoked) | Short-acting, intense reinforcement; cardiac risk |
| Methamphetamine | Forces dopamine release and blocks reuptake | 10-12 hr | Long half-life, neurotoxic to dopamine terminals |
| Amphetamine / ADHD stimulants (Adderall, dextroamphetamine) | Releases dopamine and norepinephrine | 9-14 hr | Therapeutic at prescribed doses; misuse common in students |
| Methylphenidate (Ritalin, Concerta) | Blocks dopamine and norepinephrine reuptake | 2-4 hr (immediate release) | Similar misuse pattern as amphetamines |
| MDMA (ecstasy) | Releases serotonin, dopamine, norepinephrine | 6-9 hr | Empathogen; hyperthermia and serotonin syndrome risk |
| Nicotine | Stimulates nicotinic acetylcholine receptors then dopamine | ~2 hr | Strong reinforcement, very high relapse rate |
Stimulant withdrawal — the crash — is dysphoric and exhausting but is not medically dangerous in most healthy adults; suicide risk during the crash, however, is real and must be assessed. Cocaine mixed with alcohol forms cocaethylene, a longer-acting and more cardiotoxic metabolite the exam may name.
Hallucinogens / Dissociatives
- Classic hallucinogens (LSD, psilocybin, mescaline, DMT) — partial agonists at 5-HT2A serotonin receptors. Long duration (LSD 8-12 hr). Low addiction liability but rapid tolerance; bad trips and hallucinogen persisting perception disorder (HPPD) are key risks.
- Dissociatives (ketamine, PCP, dextromethorphan) — NMDA glutamate receptor antagonists. Cause detachment from body or reality. PCP is linked to violent agitation; ketamine has therapeutic uses in depression at low doses but produces dependence with chronic recreational use.
Cannabis
- Delta-9-THC is a partial agonist at CB1 cannabinoid receptors densely expressed in the hippocampus, cerebellum, and prefrontal cortex.
- Cannabis Use Disorder is recognized in DSM-5-TR; daily use raises addiction risk substantially.
- Withdrawal: irritability, anxiety, sleep disturbance, decreased appetite, vivid dreams; begins within 24-72 hours and peaks in the first week.
- Synthetic cannabinoids (K2, Spice) are full agonists with unpredictable potency and serious psychiatric and cardiac toxicity.
Inhalants
Inhalants are a heterogeneous group of volatile solvents, aerosols, gases, and nitrites (glue, paint thinner, butane, nitrous oxide, amyl nitrite). They produce rapid intoxication through diffusion across pulmonary membranes. Risks include:
- Sudden Sniffing Death Syndrome — fatal cardiac arrhythmia, even on first use.
- Permanent leukoencephalopathy and peripheral neuropathy with chronic use.
- High prevalence among adolescents because the products are legal and accessible.
Route to Reinforcement Hierarchy
The faster a drug reaches the brain, the more reinforcing it is. From most to least addictive route:
- Smoking / inhalation (seconds)
- Intravenous injection (15-30 seconds)
- Intranasal (snorting) (3-5 minutes)
- Oral (15-60 minutes)
This is why crack cocaine is more addictive than powdered cocaine taken intranasally, and why heroin smoked or injected is more addictive than oral oxycodone taken as prescribed.
A client takes high-dose alprazolam daily and also drinks heavily. Which combination of mechanisms makes this client at highest risk for fatal respiratory depression?
Which statement about half-life and withdrawal is MOST accurate for ADC clinical practice?
A 17-year-old is brought to the emergency department after huffing aerosol propellant. Which acute risk is MOST associated with inhalant use?
Buprenorphine is best described pharmacologically as which of the following at the mu opioid receptor?